Notably, in NSCLC with concurrent LKB1 and KEAP1 mutations, SHMT1 expression is further upregulated through NRF2-mediated activation, contributing to serine-glycine 1-carbon metabolism and supporting tumor cell survival under oxidative stress (Lee et al., 2024a). This evidence concerns the gene SHMT1 and neoplasm.